These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Application of aqueous two-phase systems in separation/purification of stroma free hemoglobin from animal blood. Kan P; Lee CJ Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):641-9. PubMed ID: 7994385 [TBL] [Abstract][Full Text] [Related]
4. Development of analytical methods to evaluate SFH. Nakai K; Abe H; Matsuda N; Kobayashi M; Ikeda H; Sekiguchi S; Tsuchida E Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):447-51. PubMed ID: 1391462 [TBL] [Abstract][Full Text] [Related]
5. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum. Hsiao LL; Howard RJ; Aikawa M; Taraschi TF Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):121-32. PubMed ID: 2001227 [TBL] [Abstract][Full Text] [Related]
8. Studies on the quality control of stroma-free hemoglobin. Sekiguchi S Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):407-14. PubMed ID: 1391456 [TBL] [Abstract][Full Text] [Related]
9. Coisolation of glycophorin A and polyphosphoinositides from human erythrocyte membranes. Buckley JT Can J Biochem; 1978 May; 56(5):349-51. PubMed ID: 208725 [TBL] [Abstract][Full Text] [Related]
10. Pilot scale production of pyrogen-free human hemoglobin for research. Chapman KW; Snell SM; Jesse RG; Morano JK; Everse J; Winslow RM Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):415-21. PubMed ID: 1391457 [TBL] [Abstract][Full Text] [Related]
11. Measurement of interleukin-6 production by monocytes for in vitro safety testing of hemoglobin solutions. Bleeker WK; de Groot EM; den Boer PJ; Biessels PT; Aarden LA; Bakker JC Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):835-40. PubMed ID: 7994407 [TBL] [Abstract][Full Text] [Related]
12. Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity. Bakker JC; Bleeker WK; Den Boer PJ; Biessels PT; Agterberg J; Rigter G; Holthuis JC; Mertens K Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):577-85. PubMed ID: 7994377 [TBL] [Abstract][Full Text] [Related]
13. Extraction of Phospholipids from Human Erythrocyte Membranes by Hemoglobin Oxidation Products. Brunauer LS; Chen JY; Koontz MZ; Davis KK; O'Brien LE; Wright EM; Huestis WH J Membr Biol; 2016 Jun; 249(3):305-17. PubMed ID: 26762383 [TBL] [Abstract][Full Text] [Related]
14. Large-scale blood substitute production using a microfluidizer. Vivier A; Vuillemard JC; Ackermann HW; Poncelet D Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):377-97. PubMed ID: 1391454 [TBL] [Abstract][Full Text] [Related]
15. Detection of red cell membrane components in human hemoglobin preparations. Thevenin BJ; Shohet SB Methods Enzymol; 1994; 231():17-21. PubMed ID: 8041250 [No Abstract] [Full Text] [Related]
16. Large scale production and characterization of lyophilized pyridoxalated hemoglobin-polyoxyethylene (PHP). Matsumura S; Yamaji K; Ohki H; Kosaka K; Iwashita Y Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):435-8. PubMed ID: 1391459 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of toxicity of hemoglobin solutions. Feola M; Simoni J; Tran R; Canizaro PC Biomater Artif Cells Artif Organs; 1988; 16(1-3):217-26. PubMed ID: 3179466 [No Abstract] [Full Text] [Related]
18. Effects of modified hemoglobin solutions on the isolated rabbit heart. Biessels PT; Hak JB; Bleeker WK; van Beek JH; Bakker JC Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):693-6. PubMed ID: 1391498 [TBL] [Abstract][Full Text] [Related]